Integra LifeSciences Executive and Leadership Team

Stuart Essig, the Chairman, President & Chief Executive Officer at Integra LifeSciences, directs the overarching strategic vision for the global medical technology portfolio. Overseeing the integration of neurosurgical devices and advanced wound care systems, the Chairman, President & Chief Executive Officer ensures alignment between corporate objectives and the evolving needs of neurocritical care teams. This leadership role involves managing complex market expansions across international territories while maintaining rigorous standards for surgical instrument manufacturing. By prioritizing innovation in tissue repair and cranial stabilization, Stuart Essig drives the long-term growth trajectory of the organization. The Chairman, President & Chief Executive Officer maintains constant communication with the Board to refine operational efficiency and market positioning. Through consistent focus on high-growth segments, the executive secures the competitive advantage of the company within the global healthcare landscape, ultimately fostering sustainable value for stakeholders and patients requiring complex reconstructive care.

Lea Knight, the Executive Vice President & Chief Financial Officer at Integra LifeSciences, directs the financial planning, reporting, and capital allocation strategies of the organization. Overseeing the fiscal health of the company, the Executive Vice President & Chief Financial Officer ensures that resources are effectively deployed to support the development of neurosurgical devices and advanced wound care products. This leadership role involves managing investor relations and providing transparent financial guidance to the Board. By implementing rigorous cost-control measures and optimizing the balance sheet, Lea Knight drives the financial stability required for long-term research and development investments. The Executive Vice President & Chief Financial Officer collaborates with operational leaders to assess the profitability of various product segments, including cranial stabilization and soft tissue repair. Through disciplined financial oversight, the executive supports the strategic growth initiatives of the company, ensuring that the organization remains well-positioned to navigate the competitive medical technology market.

Russell Olsen, the President of Advanced Wound Care at Integra LifeSciences, directs the specialized business unit focused on acute and chronic wound management. Overseeing the development and commercialization of products for burns and diabetic foot ulcers, the President of Advanced Wound Care ensures that the organization provides comprehensive solutions for tissue repair. This leadership role involves managing the specific supply chain and clinical support requirements for wound care products. By identifying market opportunities in the global wound management sector, Russell Olsen drives the growth of this critical business segment. The President of Advanced Wound Care coordinates with the broader commercial organization to ensure that wound care solutions are integrated into the overall surgical portfolio. Through strategic focus on patient recovery and tissue regeneration, the executive ensures that the company maintains its leadership position in providing effective, specialized treatments for complex wounds, ultimately enhancing the quality of life for patients worldwide.

Chantal Veillon, the Executive Vice President & Chief Human Resources Officer at Integra LifeSciences, directs the global talent strategy and organizational development initiatives. Overseeing the recruitment and retention of specialized professionals, the Executive Vice President & Chief Human Resources Officer ensures that the workforce possesses the technical expertise required to manufacture complex neurosurgical and wound care products. This leadership role involves designing comprehensive training programs that align with the mission of supporting neurosurgeons and ENT specialists. By fostering a culture of innovation and operational excellence, Chantal Veillon drives employee engagement across all manufacturing facilities and corporate offices. The Executive Vice President & Chief Human Resources Officer collaborates with other C-suite leaders to implement performance management systems that support the growth of the company. Through strategic workforce planning, the executive ensures that the organization maintains the human capital necessary to sustain its position as a leader in medical technology.

Christopher Schutt, the Vice President, Operations & Chief Marketing Officer, Office of Excellence at Integra LifeSciences, directs the intersection of manufacturing efficiency and market-facing product strategy. Overseeing the Office of Excellence, the Vice President, Operations & Chief Marketing Officer, Office of Excellence ensures that surgical headlamps and general surgical instruments meet the highest quality standards while reaching target markets effectively. This leadership role involves streamlining production workflows to support the global demand for neurosurgical and tissue repair solutions. By analyzing market trends and clinical feedback, Christopher Schutt architects marketing campaigns that highlight the unique value proposition of the product portfolio. The Vice President, Operations & Chief Marketing Officer, Office of Excellence coordinates with commercial teams to ensure that operational output aligns with sales objectives. Through the optimization of internal processes, the executive drives significant improvements in product delivery and customer satisfaction across the global healthcare network.

Teshtar Elavia, the Corporate Vice President & Chief Technology Officer at Integra LifeSciences, directs the research and development pipeline for next-generation surgical technologies. Overseeing the engineering teams, the Corporate Vice President & Chief Technology Officer ensures that the company remains at the forefront of innovation in neurosurgical tools and tissue repair systems. This leadership role involves identifying emerging clinical needs and translating those requirements into advanced product designs, such as surgical navigation systems and balloon technologies for sinus dilation. By fostering collaboration between R&D and clinical specialists, Teshtar Elavia drives the creation of solutions that improve patient outcomes in neurocritical care and ENT surgery. The Corporate Vice President & Chief Technology Officer manages the intellectual property portfolio and ensures that all technological advancements align with the long-term product roadmap. Through continuous investment in technical capabilities, the executive secures the future competitiveness of the organization in the complex medical device industry.

Dimitri Kvares, the Corporate Vice President & Chief Information Officer at Integra LifeSciences, directs the digital infrastructure and cybersecurity strategy of the organization. Overseeing the integration of enterprise systems, the Corporate Vice President & Chief Information Officer ensures that data flows seamlessly across global manufacturing and distribution operations. This leadership role involves implementing advanced analytics platforms that support decision-making for neurosurgical and wound care product lines. By modernizing the IT landscape, Dimitri Kvares drives operational efficiency and protects the integrity of sensitive clinical and corporate data. The Corporate Vice President & Chief Information Officer collaborates with other executives to leverage technology for improved customer engagement and supply chain visibility. Through the deployment of scalable digital solutions, the executive ensures that the company maintains a robust technological foundation, enabling the organization to respond rapidly to the evolving demands of the global healthcare market and its diverse surgical partners.

Michael McBreen, the Chief Commercial Officer at Integra LifeSciences, directs the global sales strategy and commercial execution for the entire product portfolio. Overseeing the direct sales teams and distribution partnerships, the Chief Commercial Officer ensures that neurosurgical devices and tissue repair products reach hospitals and surgery centers worldwide. This leadership role involves developing go-to-market strategies that address the specific needs of neurosurgeons, ENT specialists, and general surgeons. By analyzing regional market performance, Michael McBreen drives revenue growth and expands the reach of the company into new clinical territories. The Chief Commercial Officer coordinates with marketing and product management to ensure that sales teams are equipped with the necessary tools and clinical knowledge to succeed. Through the cultivation of strong relationships with healthcare providers, the executive ensures that the organization remains the preferred partner for complex surgical and reconstructive care, consistently delivering value to the clinical community.

Raymond Turner, the Corporate Vice President & Chief Medical Officer at Integra LifeSciences, directs the clinical strategy and medical affairs initiatives for the organization. Overseeing the evaluation of clinical evidence, the Corporate Vice President & Chief Medical Officer ensures that all neurosurgical and wound care products meet the highest standards of safety and efficacy. This leadership role involves engaging with the medical community to understand the clinical challenges faced by neurocritical care teams and reconstructive surgeons. By providing medical guidance for product development and regulatory submissions, Raymond Turner drives the scientific credibility of the company. The Corporate Vice President & Chief Medical Officer collaborates with R&D and commercial teams to ensure that clinical insights inform the product roadmap. Through the oversight of clinical trials and medical education programs, the executive ensures that the organization remains committed to improving patient outcomes and advancing the standard of care in complex surgical procedures.

Valdevir Aquino, the Country Manager Brasil at Integra LifeSciences, directs all commercial activities and market penetration strategies within the South American region. Overseeing the distribution of neurosurgical tools and tissue repair products, the Country Manager Brasil ensures that local healthcare providers receive consistent access to advanced surgical instrumentation. This leadership role involves navigating complex regulatory environments and building robust partnerships with hospitals and surgery centers throughout the territory. By optimizing supply chain logistics and local sales team performance, Valdevir Aquino expands the footprint of the company in critical medical markets. The Country Manager Brasil coordinates with global leadership to adapt product offerings to regional clinical requirements, ensuring that the portfolio meets the specific needs of plastic and reconstructive surgeons. Through strategic engagement with key opinion leaders, the executive strengthens the brand presence and operational reliability of the organization across the entire Brazilian healthcare sector.